SPRY
Ars Pharmaceuticals Inc
Biopharmaceutical company developing treatments for severe allergic reactions
CUSIP: 82835W108HealthcareUS1 holder
Total Value
$6.48M
Total Shares
556.2K
Net Share Change
+556.2K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Third Point LLC
$6.48M556.2K sharesNEW